We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+10.03%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$55B
AUM Growth
+$6.6B
Cap. Flow
+$2.65B
Cap. Flow %
4.81%
Top 10 Hldgs %
35.14%
Holding
929
New
47
Increased
589
Reduced
189
Closed
58

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$255M
2
AAPL icon
Apple
AAPL
+$173M
3
MSFT icon
Microsoft
MSFT
+$166M
4
JPM icon
JPMorgan Chase
JPM
+$134M
5
AMZN icon
Amazon
AMZN
+$101M

Top Sells

Rank Stock Value
1
OTIS icon
Otis Worldwide
OTIS
+$74.8M
2
ACN icon
Accenture
ACN
+$70.7M
3
ELV icon
Elevance Health
ELV
+$69.2M
4
HES
Hess
HES
+$59.9M
5
MSI icon
Motorola Solutions
MSI
+$53.7M

Sector Composition

Rank Sector Weight
1 Technology 34.07%
2 Financials 13.98%
3 Consumer Discretionary 10.82%
4 Communication Services 10.11%
5 Healthcare 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMD icon
326
ResMed
RMD
$28.3B
$26M 0.05%
94,864
+5,323
+6% +$1.45M
DD icon
327
DuPont de Nemours
DD
$18.6B
$25.8M 0.05%
263,779
+15,759
+6% +$1.48M
TSCO icon
328
Tractor Supply
TSCO
$16.3B
$25.5M 0.05%
448,307
+50,333
+13% +$2.96M
CTSH icon
329
Cognizant
CTSH
$21.5B
$25.4M 0.05%
378,718
-3,497
-0.9% -$253K
HUM icon
330
Humana
HUM
$46.7B
$25.3M 0.05%
97,431
+7,678
+9% +$2.02M
ADM icon
331
Archer Daniels Midland
ADM
$41.4B
$25.3M 0.05%
422,800
+62,603
+17% +$3.66M
MCHP icon
332
Microchip Technology
MCHP
$42.8B
$25.3M 0.05%
393,198
+33,405
+9% +$2.26M
VTR icon
333
Ventas
VTR
$48.9B
$24.9M 0.05%
356,360
+29,330
+9% +$1.97M
KGC icon
334
Kinross Gold
KGC
$28.5B
$24.9M 0.05%
1,004,185
+94,077
+10% +$1.81M
NUE icon
335
Nucor
NUE
$56.4B
$24.8M 0.05%
183,370
+10,771
+6% +$1.52M
IRM icon
336
Iron Mountain
IRM
$38.2B
$24.7M 0.04%
242,449
+14,210
+6% +$1.37M
KVUE icon
337
Kenvue
KVUE
$37B
$24.2M 0.04%
1,493,727
+61,250
+4% +$1.25M
ZS icon
338
Zscaler
ZS
$23B
$24M 0.04%
80,200
+5,114
+7% +$1.46M
EME icon
339
Emcor
EME
$33.1B
$24M 0.04%
36,907
+1,392
+4% +$844K
KEYS icon
340
Keysight
KEYS
$54.5B
$23.9M 0.04%
136,703
+7,428
+6% +$1.24M
ARES icon
341
Ares Management
ARES
$28.5B
$23.9M 0.04%
149,337
+8,950
+6% +$1.61M
FITB
342
Fifth Third Bancorp
FITB
$52B
$23.6M 0.04%
530,267
+31,001
+6% +$1.36M
CCL icon
343
Carnival Corporation Ltd
CCL
$36.1B
$23.3M 0.04%
804,730
+19,006
+2% +$574K
CAE icon
344
CAE Inc. Common Shares
CAE
$8.1B
$23.1M 0.04%
779,958
+59,423
+8% +$1.67M
NTR icon
345
Nutrien
NTR
$32.7B
$22.8M 0.04%
389,015
+22,169
+6% +$1.29M
TEVA icon
346
Teva Pharmaceuticals
TEVA
$35.9B
$22.7M 0.04%
+1,123,553
New +$19.7M
CLS icon
347
Celestica
CLS
$35.1B
$22.6M 0.04%
92,115
+10,341
+13% +$2.08M
CSGP icon
348
CoStar Group
CSGP
$11.3B
$22.6M 0.04%
268,250
+16,195
+6% +$1.43M
SYF icon
349
Synchrony
SYF
$23.7B
$22.6M 0.04%
318,125
-40,538
-11% -$2.94M
AER icon
350
AerCap
AER
$23.9B
$22.6M 0.04%
186,742
-14,905
-7% -$1.74M

Similar funds

Aviva's Q3 2025 Portfolio in Review

As of Q3 2025, Aviva held 929 positions worth $55B, up 14% from $48.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Aviva deployed $2.65B of net new capital in Q3 2025, opening 47 new positions and adding to 589 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Otis Worldwide, an estimated $74.8M trimmed.

  • Aviva's largest Q3 2025 buy was Teva Pharmaceuticals: 1,123,553 shares worth $22.7M.
  • Aviva added most to NVIDIA in Q3 2025, an estimated $255M increase.
  • Aviva's biggest Q3 2025 reduction was Otis Worldwide, cutting an estimated $74.8M.
  • Aviva fully exited Hess in Q3 2025, selling an estimated $59.9M.
  • Aviva's ten largest holdings make up 35% of its $55B portfolio in Q3 2025.
  • Aviva opened 47 new positions and closed 58 in Q3 2025.
  • Aviva's portfolio value rose 14% quarter-over-quarter to $55B.

Based on Aviva's 13F filing for Q3 2025, filed 13 Nov 2025.